Calyxt, Inc. Stock News

Political agreement on New Genomic Techniques (NGTs), including gene editing, advances a science-based path for plant breeding innovation and supports Cibus' plans to bring improved traits to European growers

Cibus, Inc. ( CBUS ) Q3 2025 Earnings Call November 13, 2025 4:30 PM EST Company Participants Carlo Broos - Chief Financial Officer Peter Beetham - Co-Founder, Interim CEO, President, COO & Director Gregory Gocal - Co-Founder, Chief Scientific Officer & Executive VP Conference Call Participants Kevin Estok - Jefferies LLC, Research Division Matthew Venezia - Alliance Global Partners, Research D...

With the addition of Centro Internacional de Agricultura Tropical (CIAT) in the quarter, Cibus now has 5 LATAM Rice customers as momentum continues toward achieving 2027 targeted initial LATAM Rice revenue On track to deliver HT traits to Latin American customer in Q4 2025 with field trials expected to commence by year end Engaged strategic growth advisory firm AgVayā to introduce Indian Rice g...

Appointment underscores company's commitment to long-term shareholder value creation and sustained business growth Appointment underscores company's commitment to long-term shareholder value creation and sustained business growth

SAN DIEGO, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS), a leading agricultural technology company that develops and licenses plant traits to seed companies, today announced that the company will report third quarter 2025 financial results on Thursday, November 13, 2025. Cibus' management team will host a conference call and audio webcast at 4:30 p.m.

Collaboration aims to accelerate the adoption of advanced gene editing technologies in and deliver high-performance traits that support more sustainable and productive rice production in India Collaboration aims to accelerate the adoption of advanced gene editing technologies in and deliver high-performance traits that support more sustainable and productive rice production in India

Field testing confirms efficacy of HT2 trait in Canola under real-world conditions HT2 trait will be offered to potential seed licensing partners for introduction into commercial Canola seed products SAN DIEGO, Oct. 02, 2025 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS) (the “Company”), a leading agricultural technology company developing and licensing advanced gene edited plant traits that en...

Appointment strengthens governance and commercialization strategy expertise as Cibus continues preparations for launch of its advanced trait technologies delivering crop productivity and sustainability solutions to farmers Appointment strengthens governance and commercialization strategy expertise as Cibus continues preparations for launch of its advanced trait technologies delivering crop prod...